Evaxion Biotech Company
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Technology:
DNA
Industry:
DNA, Early Drug Development, Preclinical Development
Headquarters:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2008-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
2
Total Funding:
57000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-09-06
Last Funding Type:
Grant
Register and Claim Ownership